MA25842A1 - Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament. - Google Patents

Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.

Info

Publication number: MA25842A1
Authority: MA; Morocco
Prior art keywords: manufacture; medicament; crystalline monohydrate; monohydrate; crystalline
Prior art date: 2000-10-12

Application number

MA27102A

Other languages

English (en)

Inventor

Rolf Banholzer

Peter Sieger

Christian Kulinna

Michael Trunk

Manfred Ludwig August Graulich

Peter Specht

Helmut Meissner

Andreas Mathes

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2003-04-08

Publication date

2003-07-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7659568&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA25842(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-04-08 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-07-01 Publication of MA25842A1 publication Critical patent/MA25842A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

MA27102A 2000-10-12 2003-04-08 Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament. MA25842A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10050621		2000-10-12

Publications (1)

Publication Number	Publication Date
MA25842A1 true MA25842A1 (fr)	2003-07-01

Family

ID=7659568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27102A MA25842A1 (fr)	2000-10-12	2003-04-08	Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.

Country Status (46)

Country	Link
EP (2)	EP1326862B1 (fr)
JP (1)	JP3764422B2 (fr)
KR (1)	KR100823860B1 (fr)
CN (2)	CN1221549C (fr)
AP (1)	AP1572A (fr)
AR (2)	AR034389A1 (fr)
AT (1)	ATE276253T1 (fr)
AU (2)	AU1499602A (fr)
BG (1)	BG66161B1 (fr)
BR (1)	BR0114584A (fr)
CA (1)	CA2425539C (fr)
CR (1)	CR6938A (fr)
CZ (1)	CZ301841B6 (fr)
DE (1)	DE50103666D1 (fr)
DK (1)	DK1326862T3 (fr)
DZ (1)	DZ3478A1 (fr)
EA (1)	EA004381B1 (fr)
EC (1)	ECSP034540A (fr)
EE (1)	EE04567B1 (fr)
EG (1)	EG24142A (fr)
ES (1)	ES2228965T3 (fr)
GE (1)	GEP20063905B (fr)
HR (1)	HRP20030276B1 (fr)
HU (1)	HU226830B1 (fr)
IL (2)	IL155335A0 (fr)
IS (1)	IS2339B (fr)
MA (1)	MA25842A1 (fr)
ME (2)	ME00243B (fr)
MX (1)	MXPA03003221A (fr)
MY (1)	MY126931A (fr)
NO (1)	NO328465B1 (fr)
NZ (1)	NZ525733A (fr)
OA (1)	OA12403A (fr)
PE (1)	PE20020422A1 (fr)
PL (1)	PL207870B1 (fr)
PT (1)	PT1326862E (fr)
RS (1)	RS50218B (fr)
SA (1)	SA01220412B1 (fr)
SI (1)	SI1326862T1 (fr)
SK (1)	SK287009B6 (fr)
TR (1)	TR200402579T4 (fr)
TW (1)	TW589313B (fr)
UA (1)	UA74215C2 (fr)
UY (2)	UY26962A1 (fr)
WO (1)	WO2002030928A1 (fr)
ZA (1)	ZA200302500B (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ME00412B (fr) *	2001-06-22	2011-10-10	Boehringer Ingelheim Pharma	Substance anticholinergique cristalline, son procede de production et son utilisation pour la production d'un medicament
US6608055B2 (en)	2001-06-22	2003-08-19	Boehringer Ingelheim Pharma Kg	Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10212264A1 (de)	2002-03-20	2003-10-02	Boehringer Ingelheim Pharma	Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7311894B2 (en)	2002-03-28	2007-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations containing an anticholinergic
DE10214263A1 (de) *	2002-03-28	2003-10-16	Boehringer Ingelheim Pharma	HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7244415B2 (en)	2002-03-28	2007-07-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	HFA suspension formulations of an anhydrate
US7056916B2 (en)	2002-11-15	2006-06-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Medicaments for the treatment of chronic obstructive pulmonary disease
DE10317461A1 (de)	2003-04-16	2004-10-28	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
JP5165244B2 (ja)	2003-11-03	2013-03-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
DK2083007T3 (da) *	2003-11-03	2013-07-29	Boehringer Ingelheim Int	Tiotropiumsalte, fremgangsmåder til deres fremstilling og lægemiddelformuleringer indeholdende disse
US7968717B2 (en)	2003-11-03	2011-06-28	Boehringer Ingelhein International Gmbh	Crystalline anhydrate with anticholinergic efficacy
ME00349B (fr) *	2003-11-03	2011-05-10	Boehringer Ingelheim Int	Nouvel anhydrate cristallin a effet anticholinergique
DE102004016179A1 (de) *	2004-03-30	2005-10-20	Boehringer Ingelheim Pharma	Verbindungen zur Behandlung von proliferativen Prozessen
DK2422786T3 (da)	2004-04-22	2014-11-17	Boehringer Ingelheim Int	Nye lægemiddelkombinationer til behandling af luftvejssygdomme
DE102004024454A1 (de)	2004-05-14	2005-12-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7220742B2 (en)	2004-05-14	2007-05-22	Boehringer Ingelheim International Gmbh	Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
ES2322148T3 (es)	2004-08-11	2009-06-17	BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG	Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) *	2004-08-13	2006-04-13	Boehringer Ingelheim International Gmbh	Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de)	2004-10-01	2006-04-06	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
EA013776B1 (ru) *	2004-10-21	2010-06-30	Бёрингер Ингельхайм Интернациональ Гмбх	Блистерная упаковка для применения в ингаляторах
CA2600636A1 (fr) *	2005-03-09	2006-09-14	Boehringer Ingelheim International Gmbh	Nouvelles compositions pharmaceutiques a base d'anticholinergiques et d'inhibiteurs de pde 5
JP5053997B2 (ja)	2005-04-28	2012-10-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	炎症性疾患の治療用の新規化合物
JP2008540367A (ja) *	2005-05-02	2008-11-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規結晶性臭化チオトロピウム
WO2006117299A2 (fr)	2005-05-02	2006-11-09	Boehringer Ingelheim International Gmbh	Formes cristallines de bromure de tiotropium
NZ564697A (en) *	2005-06-15	2010-04-30	Boehringer Ingelheim Int	Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
DE102005030733A1 (de)	2005-07-01	2007-01-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
EP1915158A1 (fr) *	2005-08-06	2008-04-30	Boehringer Ingelheim International GmbH	Utilisation de sels de tiotropium pour traiter l asthme grave persistant
BRPI0614410A2 (pt)	2005-08-15	2011-03-29	Boehringer Ingelheim Int	processo para preparação de betamiméticos
US20070086957A1 (en) *	2005-10-10	2007-04-19	Thierry Bouyssou	Combination of medicaments for the treatment of respiratory diseases
US7423146B2 (en)	2005-11-09	2008-09-09	Boehringer Ingelheim International Gmbh	Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
DE102005059602A1 (de)	2005-12-14	2007-06-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Mikronisierung
MX2007009987A (es) *	2005-12-19	2007-10-02	Sicor Inc	Bromuro de tiotropio puro y estable.
US8163913B2 (en)	2005-12-19	2012-04-24	Sicor Inc.	Forms of tiotropium bromide and processes for preparation thereof
DK1971332T3 (da) *	2006-01-04	2011-04-18	Boehringer Ingelheim Int	Anvendelse af tiotropium-salte til behandling af moderat vedvarende astma
RS51163B (sr)	2006-04-19	2010-10-31	Boehringer Ingelheim International Gmbh.	Dihidrotienopirimidin za lečenje zapaljenskih bolesti
EP1847543A1 (fr)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidines pour le traitement de maladies inflammatoires
US20080051582A1 (en)	2006-07-10	2008-02-28	Sicor Inc.	Process for the preparation of tiotropium bromide
CA2660186A1 (fr)	2006-08-07	2008-02-14	Boehringer Ingelheim International Gmbh	Combinaisons de medicaments pour le traitement d'affections des voies respiratoires
UY30550A1 (es)	2006-08-22	2008-03-31	Boehringer Ingelheim Int	Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP1923393A1 (fr) *	2006-11-17	2008-05-21	Boehringer Ingelheim Pharma GmbH & Co. KG	Forme cristalline de tiotropium bromide avec urée
EP1925295A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
GB0716026D0 (en) *	2007-08-16	2007-09-26	Norton Healthcare Ltd	An inhalable medicament
MX2010004026A (es)	2007-10-19	2010-04-30	Boehringer Ingelheim Int	Piperidino-dihidrotienopirimidinas sustituidas.
EP2093219A1 (fr)	2008-02-22	2009-08-26	Boehringer Ingelheim International Gmbh	Forme de sel à énantiomère pur et cristalline d'un bêtamimétique et son utilisation comme médicament
US20100272811A1 (en) *	2008-07-23	2010-10-28	Alkermes,Inc.	Complex of trospium and pharmaceutical compositions thereof
CN102256963B (zh)	2008-12-19	2014-06-11	贝林格尔.英格海姆国际有限公司	作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
EP2201934A1 (fr)	2008-12-23	2010-06-30	CHIESI FARMACEUTICI S.p.A.	Produits de formule d'aérosol de tiotropium avec stabilité chimique améliorée
WO2010101538A2 (fr)	2009-03-06	2010-09-10	Bilgic Mahmut	Nouvelles formes de cristaux
WO2011015883A1 (fr)	2009-08-07	2011-02-10	Generics [Uk] Limited	Solvate de dichlorométhane du bromure de tiotropium et son utilisation
NZ597920A (en)	2009-08-07	2014-05-30	Generics Uk Ltd	Anhydrate of tiotropium bromide
EP2513086B1 (fr)	2009-12-17	2015-04-29	Boehringer Ingelheim International GmbH	Nouveaux antagonistes pour CCR2 et utilisations associées
ES2674275T3 (es)	2009-12-17	2018-06-28	Centrexion Therapeutics Corporation	Antagonistas del receptor CCR2 y usos de los mismos
PH12012501535A1 (en)	2010-01-29	2012-10-22	Boehringer Ingelheim Int	Substituted naphthyridines and their use as syk kinase inhibitors
WO2011141474A1 (fr)	2010-05-12	2011-11-17	Boehringer Ingelheim International Gmbh	Nouveaux antagonistes des récepteurs ccr2, procédé de production associé et application comme médicaments
JP5646736B2 (ja)	2010-05-12	2014-12-24	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２受容体アンタゴニスト、これらの製造方法、及び薬物としてのこれらの使用
WO2011144501A1 (fr)	2010-05-17	2011-11-24	Boehringer Ingelheim International Gmbh	Antagonistes du récepteur ccr2 et leurs utilisations
WO2011147772A1 (fr)	2010-05-25	2011-12-01	Boehringer Ingelheim International Gmbh	Antagonistes du récepteur ccr2
US8962656B2 (en)	2010-06-01	2015-02-24	Boehringer Ingelheim International Gmbh	CCR2 antagonists
JP5959537B2 (ja)	2011-01-28	2016-08-02	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	置換ピリジニル−ピリミジン及び医薬としてのその使用
TR201102068A2 (tr) *	2011-03-03	2012-09-21	Bi̇lgi̇ç Mahmut	Tiotropyum bromür içeren kristal maddeler
WO2012171863A1 (fr)	2011-06-16	2012-12-20	Boehringer Ingelheim International Gmbh	Nouveaux antagonistes sélectifs de ccr2
EP2731941B1 (fr)	2011-07-15	2019-05-08	Boehringer Ingelheim International GmbH	Antagonistes ccr2, nouveaux et sélectifs
KR101986484B1 (ko)	2011-07-26	2019-06-10	베링거 인겔하임 인터내셔날 게엠베하	치환된 퀴놀린 및 이의 약제로서의 용도
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
CZ304368B6 (cs) *	2011-11-28	2014-04-02	Zentiva, K.S.	Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en)	2011-12-19	2012-02-29	Teva Branded Pharmaceutical Prod R & D Inc	An inhalable medicament
US9096579B2 (en)	2012-04-20	2015-08-04	Boehringer Ingelheim International Gmbh	Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
PT2914593T (pt)	2012-11-05	2017-04-03	Zentiva Ks	Estabilização de solvatos de tiotrópio
EP2913332A1 (fr) *	2014-02-27	2015-09-02	Euticals S.P.A.	Forme cristalline de bromure de tiotropium et de lactose
AU2015233654B2 (en)	2014-03-19	2018-12-06	Boehringer Ingelheim International Gmbh	Heteroaryl Syk inhibitors
US10034866B2 (en)	2014-06-19	2018-07-31	Teva Branded Pharmaceutical Products R&D, Inc.	Inhalable medicament comprising tiotropium
RU2567539C1 (ru) *	2015-02-04	2015-11-10	Индивидуальный предприниматель Михайлов Олег Ростиславович	КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ
WO2017138896A1 (fr)	2016-02-11	2017-08-17	Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti	Forme cristalline d'anhydrate de bromure de tiotropium
WO2018084817A2 (fr) *	2016-11-04	2018-05-11	Si̇ma Patent Ve Li̇sanslama Hi̇zmetleri̇ Ltd. Şti̇	Nouvelle forme d'agent actif

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (de) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ATE177941T1 (de) *	1992-12-09	1999-04-15	Boehringer Ingelheim Pharma	Stabilisierte medizinische aerosollösungen
DE19834506A1 (de) *	1998-07-31	2000-02-03	Hexal Ag	Transmucosales therapeutisches System zur Anwendung von Sildenafil
JP4672143B2 (ja) *	1998-08-04	2011-04-20	ヤゴテックアーゲー	医薬用エーロゾル製剤

2001
- 2001-09-28 WO PCT/EP2001/011225 patent/WO2002030928A1/fr not_active Ceased
- 2001-09-28 PL PL366041A patent/PL207870B1/pl unknown
- 2001-09-28 AT AT01983510T patent/ATE276253T1/de active
- 2001-09-28 SK SK436-2003A patent/SK287009B6/sk not_active IP Right Cessation
- 2001-09-28 KR KR1020037005083A patent/KR100823860B1/ko not_active Expired - Lifetime
- 2001-09-28 CN CNB018171435A patent/CN1221549C/zh not_active Ceased
- 2001-09-28 HU HU0301022A patent/HU226830B1/hu unknown
- 2001-09-28 DE DE50103666T patent/DE50103666D1/de not_active Expired - Lifetime
- 2001-09-28 EE EEP200300171A patent/EE04567B1/xx unknown
- 2001-09-28 ME MEP-2008-400A patent/ME00243B/me unknown
- 2001-09-28 EA EA200300457A patent/EA004381B1/ru not_active IP Right Cessation
- 2001-09-28 EP EP01983510A patent/EP1326862B1/fr not_active Expired - Lifetime
- 2001-09-28 DZ DZ013478A patent/DZ3478A1/fr active
- 2001-09-28 CA CA002425539A patent/CA2425539C/fr not_active Expired - Lifetime
- 2001-09-28 EP EP04016877A patent/EP1468998A1/fr not_active Withdrawn
- 2001-09-28 TR TR2004/02579T patent/TR200402579T4/xx unknown
- 2001-09-28 UA UA2003054185A patent/UA74215C2/uk unknown
- 2001-09-28 SI SI200130219T patent/SI1326862T1/xx unknown
- 2001-09-28 AP APAP/P/2003/002775A patent/AP1572A/en active
- 2001-09-28 DK DK01983510T patent/DK1326862T3/da active
- 2001-09-28 GE GE5214A patent/GEP20063905B/en unknown
- 2001-09-28 JP JP2002534314A patent/JP3764422B2/ja not_active Expired - Lifetime
- 2001-09-28 HR HR20030276A patent/HRP20030276B1/xx not_active IP Right Cessation
- 2001-09-28 ME MEP-400/08A patent/MEP40008A/xx unknown
- 2001-09-28 RS YU27303A patent/RS50218B/sr unknown
- 2001-09-28 IL IL15533501A patent/IL155335A0/xx active IP Right Grant
- 2001-09-28 AU AU1499602A patent/AU1499602A/xx active Pending
- 2001-09-28 CZ CZ20031025A patent/CZ301841B6/cs not_active IP Right Cessation
- 2001-09-28 BR BR0114584-3A patent/BR0114584A/pt not_active Application Discontinuation
- 2001-09-28 CN CNB2005100977370A patent/CN100519558C/zh not_active Ceased
- 2001-09-28 PT PT01983510T patent/PT1326862E/pt unknown
- 2001-09-28 NZ NZ525733A patent/NZ525733A/en not_active IP Right Cessation
- 2001-09-28 AU AU2002214996A patent/AU2002214996B2/en not_active Expired
- 2001-09-28 OA OA1200300107A patent/OA12403A/fr unknown
- 2001-09-28 MX MXPA03003221A patent/MXPA03003221A/es active IP Right Grant
- 2001-09-28 ES ES01983510T patent/ES2228965T3/es not_active Expired - Lifetime
- 2001-10-02 SA SA01220412A patent/SA01220412B1/ar unknown
- 2001-10-09 TW TW090124963A patent/TW589313B/zh active
- 2001-10-09 EG EG20011058A patent/EG24142A/xx active
- 2001-10-10 PE PE2001001000A patent/PE20020422A1/es active IP Right Grant
- 2001-10-10 UY UY26962A patent/UY26962A1/es not_active Application Discontinuation
- 2001-10-10 MY MYPI20014705A patent/MY126931A/en unknown
- 2001-10-12 AR ARP010104782A patent/AR034389A1/es active IP Right Grant
2003
- 2003-03-26 CR CR6938A patent/CR6938A/es unknown
- 2003-03-28 BG BG107687A patent/BG66161B1/bg unknown
- 2003-03-31 ZA ZA200302500A patent/ZA200302500B/en unknown
- 2003-04-07 EC EC2003004540A patent/ECSP034540A/es unknown
- 2003-04-08 MA MA27102A patent/MA25842A1/fr unknown
- 2003-04-09 IS IS6772A patent/IS2339B/is unknown
- 2003-04-10 IL IL155335A patent/IL155335A/en unknown
- 2003-04-11 NO NO20031694A patent/NO328465B1/no not_active IP Right Cessation
2008
- 2008-09-19 AR ARP080104109A patent/AR068527A2/es unknown
2013
- 2013-07-11 UY UY34901A patent/UY34901A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20031694L (no)	2003-04-11
IS2339B (is)	2008-02-15
RS50218B (sr)	2009-07-15
CA2425539A1 (fr)	2003-04-11
KR20030042008A (ko)	2003-05-27
TW589313B (en)	2004-06-01
EG24142A (en)	2008-08-06
EP1326862B1 (fr)	2004-09-15
KR100823860B1 (ko)	2008-04-21
JP2004526668A (ja)	2004-09-02
YU27303A (sh)	2006-05-25
AU2002214996B2 (en)	2007-03-15
EE04567B1 (et)	2005-12-15
HUP0301022A3 (en)	2005-12-28
AU1499602A (en)	2002-04-22
PL366041A1 (en)	2005-01-24
NZ525733A (en)	2005-01-28
ATE276253T1 (de)	2004-10-15
NO328465B1 (no)	2010-02-22
IS6772A (is)	2003-04-09
AR068527A2 (es)	2009-11-18
UY34901A (es)	2015-02-27
NO20031694D0 (no)	2003-04-11
CZ301841B6 (cs)	2010-07-07
CN1733761A (zh)	2006-02-15
BR0114584A (pt)	2003-08-26
IL155335A0 (en)	2003-11-23
HUP0301022A2 (hu)	2003-10-28
CN100519558C (zh)	2009-07-29
DK1326862T3 (da)	2004-11-22
BG107687A (bg)	2003-09-30
AP2003002775A0 (en)	2003-03-31
MXPA03003221A (es)	2004-12-03
TR200402579T4 (tr)	2004-12-21
ES2228965T3 (es)	2005-04-16
SA01220412B1 (ar)	2006-11-05
MY126931A (en)	2006-10-31
CN1221549C (zh)	2005-10-05
EE200300171A (et)	2003-06-16
GEP20063905B (en)	2006-08-25
SK287009B6 (sk)	2009-09-07
BG66161B1 (bg)	2011-09-30
EP1326862A1 (fr)	2003-07-16
WO2002030928A1 (fr)	2002-04-18
ZA200302500B (en)	2004-04-22
HU226830B1 (en)	2009-11-30
EP1468998A1 (fr)	2004-10-20
AP1572A (en)	2006-02-13
EA200300457A1 (ru)	2003-10-30
HK1060567A1 (en)	2004-08-13
CA2425539C (fr)	2007-04-03
UA74215C2 (uk)	2005-11-15
JP3764422B2 (ja)	2006-04-05
HRP20030276B1 (en)	2006-02-28
DZ3478A1 (fr)	2002-04-18
PE20020422A1 (es)	2002-06-28
HRP20030276A2 (en)	2005-02-28
PT1326862E (pt)	2004-11-30
MEP40008A (en)	2011-02-10
HK1086557A1 (zh)	2006-09-22
OA12403A (en)	2006-04-18
EA004381B1 (ru)	2004-04-29
ECSP034540A (es)	2003-07-25
DE50103666D1 (de)	2004-10-21
SK4362003A3 (en)	2003-08-05
CN1469877A (zh)	2004-01-21
IL155335A (en)	2009-02-11
AR034389A1 (es)	2004-02-25
CR6938A (es)	2004-10-28
SI1326862T1 (sl)	2005-02-28
ME00243B (me)	2011-05-10
PL207870B1 (pl)	2011-02-28
UY26962A1 (es)	2002-06-20

Publication	Publication Date	Title
DZ3478A1 (fr)	2002-04-18	Monohydrate cristallin, procede pour sa fabrication et son utilisation pour la fabrication d'un medicament.
HUP0401081A3 (en)	2010-06-28	Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
HUS1400005I1 (hu)	2017-08-28	Kinazolinszármazékok, elõállításuk, alkalmazásuk és ezeket tartalmazó gyógyszerek
MXPA03005018A (es)	2003-09-25	Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos, y su uso.
MXPA03005019A (es)	2003-09-25	Derivados de difenilazetidinonas, metodo para su produccion farmacos que contienen estos compuestos y su uso.
AU2002219174A1 (en)	2002-09-05	Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
ATE298748T1 (de)	2005-07-15	(1,4')-bipiperidin verbindungen
PL351148A1 (en)	2003-03-24	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
NO20015664D0 (no)	2001-11-20	Nye farmasöytisk aktive forbindelser
HUP0303699A3 (en)	2006-02-28	Substituted cinnamic acid guanidides, method for the production thereof, their use as a medicament, and a medicament containing these compounds
MXPA03000873A (es)	2003-06-06	Derivados de quinazolina, medicamentos que contienen estos compuestos, su uso y metodos para la produccion de los mismos.
MXPA02004119A (es)	2003-10-06	Nuevos ciclopropanos como antagonistas de cgrp, medicamentos que contienen estos compuestos y metodo para obtencion de los mismos.
FR2807751B1 (fr)	2005-05-20	Procede pour la preparation d'un hydro (chloro) fluoroalcane et catalyseur
FR2835522B1 (fr)	2006-04-07	Preparation pour composes sensibles a l'oxydation et son procede de fabrication
ITMI20001848A0 (it)	2000-08-08	Faramaci per l'incontinenza.
FR2801888B1 (fr)	2002-02-15	Composition diluante et desintegrante, son procede d'obtention et son utilisation
FR2827294B1 (fr)	2004-01-16	Procede discontinu de fabrication d'un polyamide
ITRM20010332A0 (it)	2001-06-11	Vaccini a subunita' e procedimenti per la loro produzione.
FR2800376B1 (fr)	2003-04-18	Procede pour la production d'alkylhalogenosilanes
EP1379530A4 (fr)	2008-04-02	Procede de preparation selective d'un compose 3-(z) propenyl-cephem
DZ3448A1 (fr)	2002-05-23	PROCEDE pour la PREPARATION D'UREE.
FR2795847B1 (fr)	2002-02-22	Procede de perfectionnement de fabrication d'un insert
MA25922A1 (fr)	2003-10-01	Procede de fabrication d'un document de securite.
FR2837102B1 (fr)	2004-10-08	Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
FR2794560B1 (fr)	2001-09-21	Procede d'aide a la lecture notamment pour malvoyant